Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging

被引:1
|
作者
Jun-Gong Zhao Gan-Sheng Feng Xiang-Quan Kong Xin Li Ming-Hua Li Ying-Sheng Cheng Department of Radiology
机构
关键词
TACE; HCC; Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging; MR;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
AIM:To assess the vascularity of hepatocellular carcinoma (HCC)before and after transcatheter arterial chemoembolization(TACE) with the quantitative parameters obtained by firstpass perfusion weighted MR imaging (FP-MRI).METHODS:Seventeen consecutive patients with one tothree lesions in liver underwent FP-MRI before treatment.FP-MRI was also performed one,three,six,nine months,and one year after TACE.The baseline signal intensity (SO)of pre-TACE and one month after TACE was analyzed,thevascularity of HCC assessed by steepest slope of the signalintensity versus time curves (SS) was blindly correlatedwith their DSA feature and clinical outcome.RESULT:No significant difference was found on baselinesignal intensity (S0) between pre-TACE and one monthafter TACE (F=0.309,P=0.583),The SS (mean,32% persecond) of lesion one month after TACE was lower than thatof pre-TACE (mean,69% per second),but with no statisticalsignificance (F=3.067,P=0.092).When local recurrenceoccurred,the time intensity curves became steeper.Thevascularity of HCC before and after TACE graded by SS closelycorrelated with that by DSA (K=0.453,P<0.05).CONCLUSION:FP-MRI is a useful criterion for selectingeffective interventional treatment for patients with HCC intheir initial treatment and during follow up.
引用
收藏
页码:1152 / 1156
页数:5
相关论文
共 50 条
  • [41] Predicting the prognosis of hepatocellular carcinoma with the treatment of transcatheter arterial chemoembolization combined with microwave ablation using pretreatment MR imaging texture features
    Liu, Jun
    Pei, Yigang
    Zhang, Yu
    Wu, Yifan
    Liu, Fuquan
    Gu, Shanzhi
    ABDOMINAL RADIOLOGY, 2021, 46 (08) : 3748 - 3757
  • [42] The Risk Assessment and Clinical Research of Bile Duct Injury After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
    Xu, Houyun
    Yu, Xiping
    Hu, Jibo
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 5039 - 5052
  • [43] Sloughing of Intraductal Tumor Thrombus of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization
    Miho Okuda
    Shiro Miyayama
    Masashi Yamashiro
    Yuichi Yoshie
    Natsuki Sugimori
    Saya Igarashi
    Yoshiko Nakashima
    Taku Sanada
    Shotaro Kosaka
    Daishu Toya
    Osamu Matsui
    CardioVascular and Interventional Radiology, 2010, 33 : 619 - 623
  • [44] Hepatobiliary and Pancreatic: Pulmonary emboli after transcatheter arterial chemoembolization for hepatocellular carcinoma
    Weng, M-T
    Chen, C-H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (08) : 1466 - 1466
  • [45] Ketone bodies as a predictor of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization
    Sasaki, Ryu
    Taura, Naota
    Miyazoe, Yuri
    Yamamichi, Shinobu
    Nakashiki, Suguru
    Yamashima, Mio
    Suehiro, Tomoyuki
    Honda, Takuya
    Shibata, Hidetaka
    Ozawa, Eisuke
    Miuma, Satoshi
    Akazawa, Yuko
    Miyaaki, Hisamitsu
    Matsumoto, Takehiro
    Nakao, Kazuhiko
    Ashizawa, Kazuto
    NUTRITION, 2018, 50 : 97 - 103
  • [46] Delayed cerebral lipiodol embolism after transcatheter arterial chemoembolization of hepatocellular carcinoma
    WU JianjunCHAO MingZHANG Guangqiang and LI Bin Department of Radiologythe Second HospitalSchool ofMedicineZhejiang UniversityHangzhouZhejiang China
    中华医学杂志(英文版), 2009, (07) : 878 - 880
  • [47] Biliary migration of hepatocellular carcinoma fragment after transcatheter arterial chemoembolization therapy
    Spahr, L
    Frossard, JL
    Felley, C
    Brundler, MA
    Majno, PE
    Hadengue, A
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (02) : 243 - 244
  • [48] Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma
    Huang, Yao-Kuang
    Yen, Chieh-Ling
    Shiu, Sz-Iuan
    Lee, Shou-Wu
    Chang, Pi-Yi
    Yeh, Hong-Zen
    Lee, Teng-Yu
    PLOS ONE, 2017, 12 (11):
  • [49] Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization
    Xu, Li
    Peng, Zhen-Wei
    Chen, Min-Shan
    Shi, Ming
    Zhang, Yao-Jun
    Guo, Rong-Ping
    Lin, Xiao-Jun
    Lau, Wan-Yee
    JOURNAL OF HEPATOLOGY, 2015, 63 (01) : 122 - 130
  • [50] Hepatocellular carcinoma supplied by portal flow after repeated transcatheter arterial chemoembolization
    Choi, SH
    Chung, JW
    Lee, HS
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (03) : 889 - 890